Literature DB >> 908761

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

E Ipp, R E Dobbs, V Harris, A Arimura, W Vale, R H Unger.   

Abstract

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of pancreozymin-cholecystokinin on immunoreactive somatostatin release were studied in the isolated perfused dog pancreas. Gastrin at a concentration of 65 ng/ml and the octapeptide of pancreozymin-cholecystokinin at a concentration of 25 ng/ml produced a prompt, but transient statistically significant, twofold rise in mean somatostatin concentration. Secretion at a concentration of 0.3 U/ml and gastric inhibitory polypeptide concentration of 58 ng/ml produced a prompt two- to threefold rise in mean somatostatin release, which persisted throughout the perfusion period. With all four polypeptides the pattern of the somatostatin response resembled that of insulin. It appears that pancreatic somatostatin release is stimulated by gastrointestinal hormones that influence the secretion of insulin and glucagon.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908761      PMCID: PMC372476          DOI: 10.1172/JCI108875

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  AN INTESTINAL HORMONE AFFECTING GLUCOSE DISPOSAL IN MAN.

Authors:  J DUPRE
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus.

Authors:  R H Unger; E Ipp; V Schusdziarra; L Orci
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

4.  Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

Authors:  S R Bloom; C H Mortimer; M O Thorner; G M Besser; R Hall; A Gomez-Pan; V M Roy; R C Russell; D H Coy; A J Kastin; A V Schally
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

5.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

6.  Response of pancreatic immunoreactive somatostatin to arginine.

Authors:  G S Patton; E Ipp; R E Dobbs; L Orci; W Vale; R H Unger
Journal:  Life Sci       Date:  1976-12-15       Impact factor: 5.037

7.  Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose.

Authors:  P Schauder; C McIntosh; J Arends; R Arnold; H Frerichs; W Creutzfeldt
Journal:  FEBS Lett       Date:  1976-10-01       Impact factor: 4.124

8.  Pancreatic immunoreactive somatostatin release.

Authors:  G S Patton; E Ipp; R E Dobbs; L Orci; W Vale; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.

Authors:  E Ipp; R E Dobbs; A Arimura; W Vale; V Harris; R H Unger
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

10.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  22 in total

1.  Helodermin and islet hormone release in isolated rat pancreas.

Authors:  H C Fehmann; R Göke; B Göke; R Eissele; R Arnold
Journal:  Int J Pancreatol       Date:  1991-05

2.  Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat.

Authors:  G L Ricci; J Fevery
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

3.  Pancreatic somatostatin secretion is suppressed by splanchnic nerve stimulation.

Authors:  M W Roy; M S Jones; R E Miller
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

4.  Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.

Authors:  J M Conlon; C B Srikant; E Ipp; V Schusdziarra; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

Authors:  M Otsuki; C Sakamoto; H Yuu; M Maeda; S Morita; A Ohki; N Kobayashi; K Terashi; K Okano; S Baba
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

6.  Localization of cholecystokinin receptor subtypes in the endocine pancreas.

Authors:  Jean Morisset; Sophie Julien; Jean Lainé
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

7.  Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.

Authors:  V Schusdziarra; V Harris; J M Conlon; A Arimura; R Unger
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.

Authors:  G J Taborsky; J W Ensinck
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Effect of caerulein administration on portal plasma somatostatin in dogs.

Authors:  J Kasanuki; S Fujimoto; H Makino; A Kanatsuka; T Imaizumi; H Koseki; R Kaneko; Y Tokumasa; S Yoshida
Journal:  Gastroenterol Jpn       Date:  1984-06

10.  Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells.

Authors:  Karim El-Kouhen; Jean Morisset
Journal:  Int J Endocrinol       Date:  2009       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.